期刊文献+

粪便肠脱落细胞端粒酶活性检测对大肠癌的早期诊断价值 被引量:3

Value of detecting Telomerase activity in colorectal exfoliated cell for early diagnosis of colorectal cancer
下载PDF
导出
摘要 目的探讨粪便肠脱落细胞、组织细胞中端粒酶活性表达对大肠癌早期诊断的意义。方法端粒酶PCR-ELISA检测法检测30例大肠癌患者、30例大肠腺瘤患者及30例对照组健康自愿者粪便肠脱落细胞及对应组织细胞标本中端粒酶活性表达。结果大肠癌组粪便肠脱落细胞标本中,端粒酶阳性表达率为83.3%(25/30)。大肠腺瘤组粪便肠脱落细胞标本中,端粒酶阳性表达率为66.6%(20/30)。对照组粪便肠脱落细胞中端粒酶阳性表达率为3.3%(1/30)。27例大肠癌组织端粒酶表达阳性的患者有25例其对应的粪便肠脱落细胞端粒酶活性也呈阳性表达。结论粪便肠脱落细胞端粒酶活性表达对大肠癌的早期诊断具有重要意义。 Objective To investigate the value of detecting Telomerase activity in colorectal exfoliated cell and tissue cell for early diagnosis of colorectal cancer.Methods We detected Telomerase activity by PCR-ELISA in fecal DNA and tissues DNA from 30 colorectal cancer patients versus 30 samples from adenoma patients and 30 healthy subjects.Results The positive rate of Telomerase activity detection in exfoliated cell in stool were 83.3%(25/30),66.6%(20/30) and 3.3%(1/30) of patients with colorectal cancer,adenoma and healthy subjects,respectively.Among 27 cases which were detected positive in tumor tissues,25 cases were also positive in exfoliated cell in stool.Conclusion Detection of Telomerase activity in stool has important significance in early diagnosis of colorectal cancer.
出处 《临床军医杂志》 CAS 2012年第5期1134-1136,共3页 Clinical Journal of Medical Officers
关键词 大肠肿瘤 粪便 肠脱落细胞 端粒酶 colorectal neoplasm stool colorectal exfoliated cell Telomerase
  • 相关文献

参考文献1

二级参考文献19

  • 1[1]Jemal A,Siegel R,Ward E,Murray T,Xu J,Smigal C,Thun MJ.Cancer statistics,2006.CA Cancer J Clin 2006; 56:106-130
  • 2[2]Baylin SB,Ohm JE.Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-116
  • 3[3]Kondo Y,Issa JP.Epigenetic changes in colorectal cancer.Cancer Metastasis Rev 2004; 23:29-39
  • 4[4]Chan AO,Broaddus RR,Houlihan PS,Issa JP,Hamilton SR,Rashid A.CpG island methylation in aberrant crypt foci of the colorectum.Am] Pathol 2002; 160:1823-1830
  • 5[5]Belshaw NJ,Elliott GO,Williams EA,Bradbum DM,Mills SJ,Mathers JC,Johnson IT.Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.Cancer Epidemiol Biomarkers Prev 2004; 13:1495-1501
  • 6[6]Leung WK,To KF,Man EP,Chan MW,Bai AH,HuiAJ,Chan FK,Lee JF,Sung JJ.Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer:a feasibility study.Clin Chem 2004; 50:2179-2182
  • 7[7]Muller HM,Oberwalder M,Fiegl H,Morandell M,Goebel G,Zitt M,Muhlthaler M,Ofner D,Margreiter R,Widschwendter M.Methylation changes in faecal DNA:a marker for colorectal cancer screening? Lancet 2004; 363:1283-1285
  • 8[8]Petko Z,Ghiassi M,Shuber A,Gorham J,Smalley W,Washington MK,Schultenover S,Gautam S,Markowitz SD,Grady WM.Aberrantly methylated CDKN2A,MGMT,and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.Clin Cancer Res 2005; 11:1203-1209
  • 9[9]Lenhard K,Bommer GT,Asutay S,Schauer R,Brabletz T,Goke B,Lamerz R,Kolligs FT.Analysis of promoter methylation in stool:a novel method for the detection of colorectal cancer.Clin Gastroenterol Hepatol 2005; 3:142-149
  • 10[10]Chen WD,Han ZJ,Skoletsky J,Olson J,Sah J,Myeroff L,Platzer P,Lu S,Dawson D,Willis J,Pretlow TP,Lutterbaugh J,Kasturi L,Willson JK,Rao JS,Shuber A,Markowitz SD.Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.J Natl Cancer Inst 2005; 97:1124-1132

共引文献28

同被引文献19

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部